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The purpose of this review is to highlight clinical research in osteoarthritis (OA). A literature search was
conducted using PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) with the search terms “osteoarthritis
[All Fields] AND treatment [All Fields]” and the following limits activated: humans, English language, all
adult 19þ years, published between April 1, 2014 and April 1, 2015. A second literature search was then
conducted with the search terms “osteoarthritis [All Fields] AND epidemiology [All Fields]”, with the
same limits. Reports of surgical outcome, case series, surgical technique, tissue sample or culture studies,
trial protocols, and pilot studies were excluded. Of 1523, 150 were considered relevant. Among epide-
miologic and observational clinical studies, themes included physical activity, early knee OA, and con-
ﬁdence/instability/falls. Symptom outcomes of pharmacologic treatments were reported for
methotrexate, adalimumab, anti-nerve growth factor monoclonal antibodies, strontium ranelate,
bisphosphonates, glucosamine, and chondroitin sulfate, and structural outcomes of pharmacologic
treatments for strontium ranelate, recombinant human ﬁbroblast growth factor 18, and glucosamine and
chondroitin sulfate. Symptom outcomes of non-pharmacologic interventions were reported for:
neuromuscular exercise, quadriceps strengthening, weight reduction and maintenance, TENS, thera-
peutic ultrasound, stepped care strategies, cognitive behavior therapy for sleep disturbance, acupuncture,
gait modiﬁcation, booster physical therapy, a web-based therapeutic exercise resource center for knee
OA; hip physical therapy for hip OA; and joint protection and hand exercises for hand OA. Structure
outcomes of non-pharmacologic interventions were reported for patellofemoral bracing.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
This is an important era in the clinical investigation of osteoar-
thritis (OA); a conﬂuence of advances positions investigators to
accelerate the pace of work and gains in knowledge. Towards this
mission, an annual review can help to organize the large amount of
work accomplished in the past year, a particularly useful task for a
ﬁeld as broad and heterogeneous as clinical OA. While some
themes emerged, a number of studies did not fall into a theme per
se. The OARSI deﬁnition of OA is: “a disorder involving movable
joints characterized by cell stress and extracellular matrix degra-
dation initiated by micro- and macro-injury that activates mal-
adaptive repair responses including pro-inﬂammatory pathways of
innate immunity. The disease manifests ﬁrst as a molecular
derangement (abnormal joint tissue metabolism) followed byg School of Medicine, North-
611, United States. Tel: 1-312-
ternational. Published by Elsevier Lanatomic, and/or physiologic derangements (characterized by
cartilage degradation, bone remodeling, osteophyte formation,
joint inﬂammation and loss of normal joint function), that can
culminate in illness” (http://oarsi.org/research/standardization-
osteoarthritis-deﬁnitions).
Among the most important concepts that emerged in this
annual review of the literature is continued and further apprecia-
tion of stage of pre-disease or disease and clinical phenotype, both
in terms of prognosis and suitability and likelihood of success of
speciﬁc interventions. The ultimate goal of intervention that delays
disease and disability progression in this heterogeneous condition
will necessitate clear delineation of the phenotypes and disease
stages that are encompassed by the label of OA. In recognition of
this, OARSI has made the following call:
New speciﬁc and sensitive disease endpoints are critically needed
to alleviate roadblocks to development of disease modifying thera-
peutics for OA. A key step in this process is the development of stan-
dardized deﬁnitions of OA. Standardization of OA deﬁnitions would aid
communication across the ﬁeld and help advance drug development
for OA and research by achieving consensus on globally recognizedtd. All rights reserved.
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the disease. We anticipate that these deﬁnitions could facilitate
communication about the disease among industry and non-industry
researchers, regulatory agencies, funding agencies, third party
payers, and patients.
We further anticipate that these deﬁnitions would be maintained
by OARSI and be subjected to regular reﬁnement as new scientiﬁc
advances demand. Deﬁnitions proposed are not intended to distin-
guish an OA patient uniquely from patients with other forms of
arthritis; but rather, they are intended to provide deﬁnitions of the
disease process that supersede the many and varied OA phenotypes, to
spur scientiﬁc advances, and facilitate communication with regulatory
agencies. The draft deﬁnitions can be viewed as the building blocks for
deﬁning OA phenotypes. We fully acknowledge that these building
blocks are likely most applicable to knee and hip OA, possibly helpful
for hand OA, but will require modiﬁcation for spine OA. (http://oarsi.
org/research/standardization-osteoarthritis-deﬁnitions)
The purpose of the current review is to highlight clinical
research in OA, particularly in the realms of epidemiology, obser-
vational clinical studies, pharmacologic treatment, and non-
pharmacologic interventions and strategies. Although an attempt
to summarize clinical research in OA in the past year is valuable, it
must be emphasized that this is a narrative review and that it is not
feasible to summarize all of the important ﬁndings of each of these
papers.
Methods
A literature search was conducted using PubMed (http://www.
ncbi.nlm.nih.gov/pubmed/) with the search terms “osteoarthritis
[All Fields] AND treatment [All Fields]” and the following limits
activated: humans, English language, all adult 19þ years, published
between April 1, 2014 and April 1, 2015. A second literature search
was then conducted with the search terms “osteoarthritis [All
Fields] AND epidemiology [All Fields]”, with the same limits. These
searches were repeated using Embase (http://www.embase.com/).
Reports of surgical outcome, case series, surgical technique, tissue
sample or culture studies, trial protocols, pilot studies and meeting
abstracts were excluded as were reports focusing on imaging,
biomarkers, and rehabilitation, as these topics are being summa-
rized within other reviews in this issue. Of 1523 papers identiﬁed,
150 were considered relevant.
Results
Papers are described under the heading (below) which corre-
sponds with the primary goal of the reported work. However, some
papers could have been included in more than one category. Table I
lists all papers falling within a given category.
Epidemiologic and observational clinical studies
Manuscripts are organized into certain themes that emerged
(physical activity, early OA, conﬁdence/instability/falls), followed
by sections devoted to cross-sectional studies of prevalent knee OA,
longitudinal studies dealing with incident knee OA, longitudinal
studies dealingwith knee OA progression, cross-sectional studies of
physical functioning in knee OA, longitudinal studies of physical
functioning in knee OA, hip OA, hand OA, foot OA, and pain.
Physical activity
Papers dealing with physical activity reported on the association
of activity with incident knee OA and with joint pain and stiffness,
factors associated with activity avoidance, impact of sedentary ac-
tivity, effect of walking on incident function limitation, qualitativeanalysis of symptom impact on activity, impact of time in light
intensity activity on disability outcomes, and association with
health-related utility.
In middle-aged women in the Australian Longitudinal Study on
Women's Health, physical activity between 47 and 58 years of age
was associated with lower risk of joint pain and stiffness nine years
later1. A qualitative study in Canada characterized consequences of
symptoms on physical activity in persons with self-reported knee
OA or symptoms2. Meeting physical activity guidelines was not
associated with incident radiographic or symptomatic knee OA in
middle-aged or older adults in the Johnston County Osteoarthritis
Project3. Knee pain and lower vitality were associated with activity
avoidance4.
Being less sedentary was associated with better function in the
Osteoarthritis Initiative, independent of moderate-vigorous phys-
ical activity minutes5. More walking was associated with a lower
risk of incident function limitation in persons with or at higher risk
for knee OA in the Multicenter Osteoarthritis Study6. Greater daily
time in light intensity physical activity was associatedwith reduced
onset and progression of disability in Osteoarthritis Initiative par-
ticipants7. There was a graded association between sedentary
behavior and elevated systolic blood pressure, independent of
moderate-vigorous physical activity minutes, in persons with or at
higher risk for knee OA in the Osteoarthritis Initiative8. In another
report utilizing the Osteoarthritis Initiative, physical activity level
was associated with health-related utility9.
Early OA
Papers dealing with early OA reported on the ﬁrst activities to
become painful in knee OA, prediction of early knee OA, signiﬁ-
cance of minor radiographic features, signiﬁcance of pre-
radiographic MRI lesions, and impact of rapid radiographic
change in early OA.
In persons without radiographic OA in the Osteoarthritis
Initiative, incident radiographic OA was associated with a prior
trajectory of increasing knee pain, stiffness, and difﬁculties with
functional tasks; over the 4-year study period there was no change
in symptoms in the control knees which did not develop OA10. Pain
and difﬁculty with activities associated with higher dynamic
loading were associated with longer prodromal phases10. In per-
sons with or at higher risk for knee OA in the Osteoarthritis
Initiative, knee pain was most likely to ﬁrst appear during
weightbearing activities involving bending, such as using stairs11.
Questionnaire variables, genetic markers, other-site OA, and
biochemical markers added only modestly to prediction of knee OA
incidence using age, gender, and body mass index (BMI) in the
Rotterdam Study-I; doubtful minor X-ray features strongly pre-
dicted future knee OA12. In persons Kellgren and Lawrence radio-
graphic grade 0 in both knees in the Osteoarthritis Initiative,
baseline cartilage damage, bonemarrow lesions, andmeniscal tears
were associated with persistent symptoms in the next 4 years13. In
persons with early symptomatic knee OA in the Osteoarthritis
Initiative and in the Cohort Hip and Cohort Knee Study, rapid
radiological change was associated with worsening of pain and
function14. Young and active athletes in a study in Qatar had a
greater risk of manifesting early OA features15.
Conﬁdence/instability/falls
The spectrum of knee conﬁdence, instability, and falls emerged
as a theme, including manuscripts dealing with factors associated
with knee conﬁdence, consequences of knee buckling, fall risk in
the setting of OA, the bone mineral density/fracture relationship in
OA, and the combined impact of falls and OA on function.
Worse knee conﬁdence was associated with pain, self-reported
knee instability, weakness, and varusevalgus motion during gait in
Table I
OA papers identiﬁed within each category
Category of research Citations identiﬁed falling within category
Physical activity and OA 1e9
Early OA 10e15
Conﬁdence/instability/falls and OA 16e20
Cross-sectional studies dealing with prevalent knee OA 21e31
Longitudinal studies dealing with incident knee OA 3,12,13,32e36
Longitudinal studies dealing with knee OA disease progression 38e44
Physical functioning in knee OA e cross-sectional studies 5,17,19,45e53
Physical functioning in knee OA e longitudinal studies 6,14,54e57
Disability 7
Hip OA 51,58e61
Hand OA 52,62e67
Foot OA 53,68e70
Pain/symptoms and OA 2,4,10,11,13,14,16,21,25,28,29,39,41,46,51,52,64,70e86
Symptom outcome of pharmacological treatments for OA 87e102
Structural outcome of pharmacological treatments for OA 103e107
Symptom outcome of non-pharmacological treatments for OA 108e130
Structural outcome of non-pharmacological treatments for OA 131
Prevalence and impact of OA 132e139
Health services research in OA 9,140e146
Research priorities in OA 147,148
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buckling and the sensation of instability without buckling was
associated with fear of falling, poor balance conﬁdence, activity
limitations, and poor function in the Multicenter Osteoarthritis
Study17. In a longitudinal study with mean follow-up of 6 years
from the Johnston County Osteoarthritis Project, the odds of falling
increased with an increasing number of lower limb symptomatic
OA joints (from 53% higher odds with one joint to 85% higher odds
with 3e4 OA joints)18. Fall history and knee OA (vs neither or only
one) was associated with worse KOOS-QoL and SF12 Physical
Component Summary scores, in persons with or at higher risk for
knee OA in the Osteoarthritis Initiative19. Fracture risk was higher
in women with OA (Dubbo Osteoporosis Epidemiology Study) than
thosewithout OA; however, the associationwas mainly observed in
women with osteopenic BMD (for vertebral and limb fracture, but
not hip fracture) and normal BMD and not in those with
osteoporosis20.
Cross-sectional studies dealing with prevalent knee OA
Type 3 ﬁnger length pattern, an indicator of prenatal androgen
exposure, was associated with symptomatic (but not radiographic)
knee OA, chronic pain, and hand OA in the Rotterdam Study21.
Almost half of the association between elevated BMI and knee OA
was explained by serum leptin level in the Maintenance of Balance,
Independent Living, Intellect, and Zest in the Elderly Boston
Study22. In the Netherlands Epidemiology of Obesity study, knee OA
was associated with weight and fat-free mass, adjusting for meta-
bolic factors, and hand OA was associated with the metabolic
syndrome, adjusting for weight23. In a study of patients undergoing
total knee or hip replacement due to primary OA in Newfoundland,
Canada, metabolomics analysis of synovial ﬂuid samples demon-
strated metabolically distinct subgroups24.
Knee extensor and ﬂexor muscle strength were associated with
knee symptoms but not radiographic severity of knee OA in the
Osteoarthritis Initiative25. In the Multicenter Osteoarthritis Study,
as compared to limbs without knee OA, limbs with lateral knee OA
had a reduced femoral offset, an increased height of hip center, a
more valgus neck-shaft angle, and an increased abductor angle, and
limbs withmedial knee OA had amore varus neck-shaft angle and a
decreased abductor angle26. The relationship between the external
knee adduction moment and directly measured medial tibiofe-
moral contact forces was generally good but varied across subjectsand activities in a study in the US, illustrating the limitations of
relying solely on the adduction moment to infer medial joint
loading when excessive directed cocontraction of muscles exists27.
Patellofemoral OAwas common in middle aged individuals with
chronic patellofemoral pain in a study in Australia28. In persons
with predominant patellofemoral OA in a UK study, greater
arthrogenous quadriceps muscle inhibition was associated with
more severe knee pain but less severe bone marrow lesion score29.
In a study including cases from the UK High Bone Mass study vs
unaffected family members and general population controls from
the Chingford and Hertfordshire cohort studies, interrelationships
were observed between osteophytes, enthesophytes, and high
bone mass, supporting a subset of knee OA characterized by excess
bone formation30. While overall number and size of bone spurs
were similar in patients with psoriatic arthritis and hand OA in a
study in Germany utilizing high-resolution peripheral quantitative
computer tomography, anatomic sites differed: in psoriatic
arthritis, radial side; and in OA, palmar and dorsal quadrants31.
Longitudinal studies dealing with incident knee OA
Effusion-synovitis and Hoffa-synovitis were associated with
incident radiographic OA in Osteoarthritis Initiative participants32.
In another report from the Osteoarthritis Initiative, among knees
without knee OA at baseline, recent knee injury was associated
with accelerated development of end-stage knee OA33. In middle
aged, overweight women without knee OA in the Prevention of
Knee Osteoarthritis in Overweight Females study, varus alignment
was associated with incident radiographic OA; the association for
valgus was borderline34. Serum leptin at baseline was associated
with MRI lesions 10 yrs later in the Michigan Study of Women's
Health Across the Nation35. A systematic review and meta-analysis
showed that knee extensor muscle weakness was associated with
an increased risk of developing symptomatic knee OA36.
Longitudinal studies dealing with knee OA disease progression
Frequent milk consumption was associated with reduced pro-
gression of knee OA inwomen in the Osteoarthritis Initiative (Lu)37.
Vitamin D deﬁciency at 30 or 36 months was associated with
24e48 month knee OA progression in Osteoarthritis Initiative
participants38. In older adults with and without OA in the Tasma-
nian Older Adult Cohort study, moderate vitamin D deﬁciency was
associated with incident or worsening knee pain over 5 years39. In
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phylloquinone (vitamin K1) was associated with progression of
articular cartilage and meniscal damage in older individuals with
and without OA40.
In knees with medial meniscal tears in a study in Australia,
weight gain was associated with concurrent cartilage loss and
pain41. In a 1-year ultrasound study of knee OA in The Netherlands,
effusion and/or synovial hypertrophywere present in >40% at some
time in the year and ﬂuctuated; Baker's cyst andmeniscal extrusion
were present and stable42. High total body BMD was associated
with an increase in femoral cartilage thickness, high spine BMD
with an increase in femoral and lateral tibial cartilage thickness,
and high medial tibial subchondral BMDwith an increase in medial
tibial cartilage thickness in persons with knee OA in the Tasmanian
Older Adult Cohort study43. In the Osteoarthritis Initiative, a larger
medial subchondral surface ratio (a measure of compartment-
speciﬁc size mismatch) was associated with a reduced risk of
incident knee symptoms; a larger lateral ratiowas associatedwith a
reduced risk of incident and progressive lateral OA44.
Physical functioning in knee OA e cross-sectional studies
Knee OAwas associatedwith aworse SF-36 Physical Component
Summary score, as were obesity, comorbidities, and low fat free
mass in The Netherlands Epidemiology of Obesity study45. A knee-
speciﬁc function measure was associated with pain status in the
contralateral knee in Osteoarthritis Initiative participants; the chair
stand performance measure best distinguished knee pain groups46.
Small increments of muscle strength were associated with clini-
cally relevant differences in a knee-speciﬁc function measure in the
Osteoarthritis Initiative47.
Individuals with symptomatic knee OA in a study in the US had
lower energetic recovery at self-selected walking speeds vs healthy
controls; ﬁndings suggested reduced effective exchange of poten-
tial and kinetic energy and increased muscular work required to
control center of mass movements48. In older adults with advanced
knee OA and chronic pain in a US study, age, function self-efﬁcacy,
and opioid use were associated with slower gait speed49. In a large
dataset comprising cohorts from six European countries, lower
extremity OA at the hip or knee was associated with worse physical
performance (walking speed, chair rises, balance); those at highest
risk had OA at both hip and knee50.
Physical functioning in knee OA e longitudinal studies
In the Cohort Hip and Cohort Knee study, 3-year decrease in
muscle strength was associated with concurrent worsening in
performance based measures of function54. In another study of this
cohort, three trajectories of function outcome were identiﬁed;
moderate and poor outcome groups were characterized by younger
age, higher BMI, greater pain, bony tenderness, reduced knee
ﬂexion, hip pain, osteophytosis, more comorbidities, and lower
vitality55. In a cohort of Chinese community-living older adults, OA
was among the factors associatedwithworsening in frailty status56.
In persons with knee OA, baseline sleep disturbance was associated
with greater increase in depression and function limitation57.
Hip OA
In the Johnston County Osteoarthritis Project, variations in
proximal femur shape by active shape modeling were modestly
associated with incident radiographic hip OA58. Cam-type femo-
roacetabular impingement and mild acetabular dysplasia were
each associated with development of radiographic hip OA and total
hip replacement in the Chingford 1000 Women Study59. In the
Danish working population, cumulative lifting was modestly
associated with total hip replacement in men, as was high BMI at
age 25 years and gain in BMI in both men and women60. In theAustralian Diabetes, Obesity and Lifestyle Study, low birth weight
and preterm birth were associated with total hip replacement in
adult life61. In patients scheduled to undergo total hip replacement
in a US study, hip pain was associated with self-report and per-
formance measures of function, while hip abduction strength was
associated only with performance measures51.
Hand OA
There were several papers dealing with hand OA, including
some dealing with the association between MRI-based tissue le-
sions and progression and erosion development, inﬂammatory
features and hand OA progression, hand OA and coronary heart
disease events, correlates of pain in hand OA, erosive OA as a more
severe form of disease, and prevalence and burden of carpometa-
carpal (CMC) OA.
In a study of the Oslo hand OA Cohort, MRI bone marrow lesions
and synovitis were associated with radiographic joint space nar-
rowing; synovitis, bone marrow lesions, osteophytes, and mala-
lignment were associated with development of radiographic
erosions62. Ultrasound inﬂammatory features, especially when
persistent, were associated with radiographic progression in clinic
patients in The Netherlands who met ACR criteria for hand OA63. In
persons with radiographic hand OA in the Musculoskeletal Pain in
Ullensaker Study, diabetes, lower education, female gender, familial
OA, widespread pain, poor mental health, more ﬁnger joints with
ultrasound-detected synovitis and radiographic OAwere associated
with hand pain64. Symptomatic (but not radiographic) hand OAwas
associated with increased risk of coronary heart disease events in
the Framingham Heart Study65.
In two population-based studies in North Staffordshire, a similar
frequency of joint involvement and patterning was found in erosive
OA and severe non-erosive OA, suggesting that erosive OAmay be a
more severe form of hand OA; erosive OA (vs non-erosive) was
associated with metabolic syndrome, especially dyslipidemia66.
First CMC erosive disease was found in 2.2% of the population-
based North Staffordshire cohort; 0.5% had combined ﬁrst CMC
and interphalangeal (IP) erosive disease52. First CMC erosive dis-
ease was associated with greater pain but similar function (vs non-
erosive OA)52. The prevalence of doctor-diagnosed ﬁrst CMCOAwas
1.4% (2.2% in women and 0.6% in men) in a large health care data-
base in Sweden67.
Foot OA
Studies relating to foot OA focused on factors associated with
hallux valgus, factors associated with ﬁrst metatarsophalangeal
(MTP) OA severity, prevalence of foot OA, and impact of foot pain on
function.
In the Johnston County Osteoarthritis Project, hallux valgus was
associatedwith female gender, African-American race, older age,pes
planus, knee/hip OA, and inverselywith higher BMI68. In the Clinical
Assessment Study of the Foot in the UK, ﬁrst MTP OA severity was
associated with dorsal hallux and ﬁrst MTP pain, hallux valgus, ﬁrst
IP hyperextension, and dorsal hallux and ﬁrst MTP keratotic lesions,
and decreased ﬁrst MTP dorsiﬂexion, ankle/subtalar eversion and
ankle dorsiﬂexion range69. In another report from this study, pop-
ulation prevalence of symptomatic radiographic foot OA was re-
ported to be 16.7%: at the ﬁrst MTP in 7.8%, at the ﬁrst
cuneometatarsal joint in 3.9%, at the second cuneometatarsal in
6.8%, at the navicularﬁrst cuneiform in 5.2%, and at the talonavicular
in 5.8%53. Atmost sites, prevalencewas greater inwomen, increased
with age, andwashigherwithworse socioeconomic status. Seventy-
ﬁve% with symptomatic radiographic foot OA reported disabling
symptoms53. In persons with symptomatic knee OA in the Osteo-
arthritis Initiative, 25% had foot pain (more often bilateral), the
presence of which was associated with worse function70.
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Papers focusing on pain in OA frequently dealt with mecha-
nisms, trajectories, and risk proﬁles.
In a cross-sectional study using the ﬁfth Korean National Health
and Nutrition Examination Survey, a metabolic syndrome/knee OA
association was largely explained by excess weight and not insulin
resistance; accumulation of metabolic syndrome components was
associated with pain severity71. In persons recruited from the
community and clinic with symptomatic knee OA by ACR criteria,
different quantitative sensory testing measures were associated
with clinical pain in African-Americans and non-Hispanic Cauca-
sians; reduced pain inhibition was important in all groups72.
Women in the Multicenter Osteoarthritis Study reported greater
knee pain than men regardless of KL grade; differences decreased
with adjustment for widespread pain73. Higher BMI was associated
with greater knee pain accounting for OA severity in persons with
or at high risk for knee OA in the Osteoarthritis Initiative74.
In the Generation of Models, Mechanism & Markers for Strati-
ﬁcation of Osteoarthritis Patients study, three patterns of synovitis
were identiﬁed in knee OA: (1) mainly patellar sites, associated
with KOOS pain and ICOAP constant pain; (2) mostly near the ACL,
not associated with pain or disease severity; (3) mainly at loose
bodies, associated with disease severity75. In another study of pa-
tients with knee OA by ACR clinical criteria, there was no associa-
tion between ultrasound features and knee pain severity by KOOS
pain or numeric rating scales76.
Papers dealing with sensitivity included a report that pressure-
pain threshold was associatedwith single andmultijoint symptoms
but not asymptomatic knee or hip OA in the Johnston County
Osteoarthritis Project77. A higher neuropathic pain questionnaire
score was associated with widespread reduction in the pressure-
pain threshold in persons with symptomatic, radiographic knee
OA in the UK78. Pressure-pain threshold and temporal summation
were associated with pain severity but not OA presence, severity, or
duration in persons with or at higher risk for knee OA in the
Multicenter Osteoarthritis Study79.
Other papers characterized pain experience and trajectories in
OA. Pain ﬂares in persons with symptomatic knee OA were
described most often by quality (sharp), timing (seconds-minutes),
antecedents, and consequences80. In the Mechanical Factors in
Arthritis of the Knee study in the US, a pain outcome measure was
derived based on development of unpredictable pain; good 2-year
outcome was less likely with greater catastrophizing and more
likely with greater self-efﬁcacy81. Five WOMAC-pain trajectories
over 6 years were identiﬁed in persons with symptomatic knee OA
in the Osteoarthritis Initiative, none with substantial worsening;
greater pain was associated with worse KL grade, obesity, depres-
sion, comorbidity, gender (female), non-Caucasian race, lower ed-
ucation, and younger age82. Mild/non-progressive, progressive,
moderate, improving, and severe/non-improving pain trajectories
were identiﬁed in persons with symptomatic OA in the Knee
Clinical Assessment Study; in Osteoarthritis Initiative participants,
the progressive and improving groups were less evident83.
Among other studies dealing with pain, nocturnal knee pain and
worse sleep quality were associated with knee OA severity in par-
ticipants from the Iwaki Health Promotion Project84. More people
with high knee pain/low disease burden of knee OA (vs high pain/
high OA, low pain/high OA, low pain/low OA) had widespread pain,
in persons with or at higher risk for knee OA in the Multicenter
Osteoarthritis Study85. In a placebo-controlled, double-blind trial in
participants with ﬁrst CMC OA of the right hand, after naproxen (vs
placebo), fMRI activity was reduced in brain regions commonly
associated with pain perception; changes in perceived pain in-
tensity were associated with changes in activity in regions previ-
ously associated with pain intensity86.Symptom outcome of pharmacologic treatments
Symptom outcomes of pharmacologic treatments were reported
for methotrexate, adalimumab, anti-nerve growth factor mono-
clonal antibodies, strontium ranelate, bisphosphonates, glucos-
amine, and chondroitin sulfate. Reviews included a Cochrane
review of topical rubefacients containing salicylates for chronic
conditions and systematic review and network meta-analysis to
analyze comparative effectiveness of pharmacologic interventions
for knee OA.
In persons with symptomatic knee OA in a double-blind ran-
domized placebo-controlled trial in Egypt, methotrexate reduced
pain and improved function at 28 week follow-up87. In a random-
ized, double-blind, parallel group, placebo-controlled multicenter
trial in France, adalimumab was not superior to placebo to alleviate
pain in hand OA not responsive to analgesics and NSAIDs88. In
persons with symptomatic knee OA by ACR clinical criteria, stron-
tium ranelate over 3 years was associated with knee symptom and
function improvement in the Strontium Ranelate Efﬁcacy in Knee
Osteoarthritis Trial89. Bisphosphonate users with symptomatic
knee OA in the Osteoarthritis Initiative had lower numeric rating
scale pain scores vs non-users (until year 4), but did not differ in
WOMAC pain or function90.
Studies of anti-nerve growth factor monoclonal antibodies
included a report that individuals with knee or hip OA by ACR
criteria with radiographic conﬁrmation receiving partial symptom
relief with NSAIDs may receive greater beneﬁt with tanezumab
monotherapy; adverse event frequency was higher with tanezu-
mab than with NSAIDS, and was highest with the combination91.
Adding tanezumab to diclofenac SR improved pain, function, global
assessment in patients with knee or hip OA, but higher adverse
events in the combination group suggests this approach is unfa-
vorable92. Fasinumab, in a double-blind, placebo-controlled, par-
allel group, exploratory study, was generally well tolerated; all
three doses were better than placebo for walking knee pain and
WOMAC93.
A meta-analysis of placebo-controlled trials of glucosamine for
primary or secondary OA in any synovial joint revealed that most
heterogeneity was explained by brand; trials using one product had
better outcome but large inconsistency, and low risk of bias trials
showed small effect sizes94. In a double-blind randomized clinical
trial, non-inferiority trial vs celecoxib, combined chondroitin sul-
fate and glucosamine had comparable efﬁcacy to celecoxib for
symptoms, function, and joint swelling/effusion in persons with
symptomatic knee OA at 6 months95.
Studies of NSAIDS include a report that long-term NSAID use in
the Osteoarthritis Initiative was associated with modest clinical
(but not signiﬁcant) change in stiffness, function, and structure
change at the knee96. Fixed-dose tramadol-diclofenac resulted in
greater pain reduction and was well tolerated vs tramadol-
paracetamol for acute OA ﬂare97. There was no association be-
tween traditional NSAIDs and nonfatal acute myocardial infarction
when background cardiovascular risk was low-intermediate; there
was a moderate association in those at high risk or with NSAID use
>365 days, in a nested caseecontrol study using a primary care
database in Spain98. Celecoxibwas as effective and safe as naproxen
for knee OA in a sample of Hispanic individuals99.
A Cochrane review concluded that evidence does not support
topical rubefacients containing salicylates for chronic condi-
tions100. A study of comparative effectiveness of pharmacologic
interventions for knee OA utilizing a systematic review and
network meta-analysis revealed: for pain, all interventions out-
performed oral placebo; for function, all interventions except
intraarticular corticosteroids were superior to placebo; and for
stiffness, treatments did not differ from each other101. Apparent
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grated intraarticular placebo effect. Limitations of published
studies included lack of long-term data, inadequate reporting of
safety data, possible publication bias, and few head-to-head
comparisons.
Patients taking duloxetine for knee OA or chronic low back pain
who had <10% reduction in pain after 4 weeks had limited possi-
bility for eventually achieving moderate pain reduction by the end
of 12 weeks102.
Structural outcomes of pharmacologic treatments
Structural outcomes were reported for strontium ranelate, re-
combinant human ﬁbroblast growth factor 18, and glucosamine
and chondroitin sulfate.
Strontium ranelate, 2 g/d, was associated with a beneﬁcial effect
on cartilage volume and bone marrow lesions in some regions, in a
subset of the phase III Strontium Ranelate Efﬁcacy in Knee Osteo-
arthritis Trial103. Recombinant human ﬁbroblast growth factor 18
was not associated with an effect on medial tibiofemoral cartilage
thickness (the primary outcome), but secondary end points showed
dose-dependent effects in a multicenter study conducted in
Europe, North America, and South Africa104. Glucosamine and
chondroitin sulfate use was associated with less cartilage volume
loss in an observational study (the Osteoarthritis Initiative), albeit
not in multivariable analyses105. In another study using Osteoar-
thritis Initiative data, glucosamine and chondroitin sulfate use was
not associated with symptom relief or modiﬁcation of disease
progression106. There was no evidence of structure beneﬁt by MRI
at 6 months or urinary CTX-II excretion from glucosamine in per-
sons with mild-to-moderate knee pain in a randomized, double-
blind, placebo-controlled trial107.
Symptom outcomes of non-pharmacologic treatments
Symptom outcomes of non-pharmacologic interventions were
reported for: neuromuscular exercise, quadriceps strengthening,
weight reduction and maintenance, TENS, therapeutic ultrasound,
stepped care strategies, cognitive behavior therapy for sleep
disturbance, acupuncture, gait modiﬁcation, booster physical
therapy, a web-based therapeutic exercise resource center for knee
OA; physical therapy for hip OA; and joint protection and hand
exercises for hand OA. Reviews included meta-analyses of exercise,
valgus bracing, ginger, electrical stimulation, and continuous and
pulsed ultrasound.
Exercise and physical therapy
An intensive diet and exercise program (vs diabetes support/
education) prevented incident knee pain at year 1, in overweight
adults with diabetes in the Action for Health in Diabetes study108.
Neuromuscular and quadriceps strengthening similarly improved
pain and function but did not change the external knee adduction
moment in the setting of moderate-severe medial knee OA with
varus alignment in Australia109. Neuromuscular exercise was more
effective for non-obese persons with a varus thrust; quadriceps
strengthening was more effective for obese persons without a
thrust110. Pressure-pain sensitivity, temporal summation, and pain
were reduced with exercise in patients with knee OA111. Booster
sessions with a physical therapist did not inﬂuence pain, function,
or home exercise adherence in patients with knee OA112. A sys-
tematic review andmeta-regression analysis of RCTs suggested that
single-type exercise programs were more efﬁcacious than pro-
grams including different exercise types for knee OA113. In partici-
pants with knee OA in a 12-week exercise program, among
tibiofemoral and patellofemoral MRI abnormalities, severity inpatellofemoral cartilage integrity was associated with less
improvement in physical function and strength and severity of
patellofemoral osteophyte formation with less improvement in
strength114.
A program of exercise therapy and education (vs only education)
was associated with later total hip replacement115. Hip physical
therapy did not result in pain or function improvement vs sham
treatment for painful hip OA116. For hand OA, joint protection (vs no
protection) was effective by 6 months using OARSI/OMERACT
responder criteria; hand exercise (vs no exercise) was not effec-
tive117. Home-based exercise for hand OA was well tolerated and
improved function, grip strength, pain, and fatigue in an RCT118. In
another RCT, group exercise followed by home exercise for hand OA
was well tolerated but was associated with small short-term
improvement only on self-reported measures119. Short-term night
time distal interphalangeal joint splinting was associated with
reduced pain and improved extension in a radiologist blinded, non-
randomized, internally controlled study120.
Behavioral therapy
Weight reduction in obese patients with a 1-year maintenance
improved knee OA symptoms, irrespective of type of maintenance
program121. In a double-blind RCT with active placebo, cognitive
behavior therapy for insomnia in knee OA reduced sleep mainte-
nance insomnia and pain122. In a secondary analysis of data from
the Lifestyles trial, short term sleep improvement predicted long
term improvements for sleep, pain, and fatigue that were not
attributable to psychological beneﬁts in persons with insomnia and
joint pain (likely due to OA)123. A web-based therapeutic exercise
resource center was feasible and efﬁcacious in improving pain,
function, and self-efﬁcacy in knee OA124. Telephone reinforcement
and negotiated maintenance contracts positively affected physical
activity behavior in OA125.
Complementary and alternative therapy
Studies of complementary and alternative therapies included a
randomized clinical trial, sham-controlled, revealing no additional
beneﬁt of TENS over education and exercise for knee OA126. In
another RCT, double-blind and sham-controlled, therapeutic ul-
trasound provided no additional beneﬁt over exercise training in
persons with knee OA127. Neither laser nor needle acupuncture
conferred beneﬁt over sham intervention for pain or function in
patients older than 50 years with moderate or severe chronic knee
pain128. A systematic review and network meta-analysis suggested
that pulsed ultrasound is more effective than control intervention
(i.e., sham or blank) for pain relief and function improvement in
knee OA129. In a meta-analysis of randomized placebo-controlled
trials for OA in any joint, ginger was modestly efﬁcacious and
reasonably safe for symptomatic OA, with evidence of moderate
quality based on the small number of participants and frequently
inadequate intention-to-treat analyses130.
Biomechanical intervention
Among biomechanical interventions, a meta-analysis of RCTs
suggested valgus bracing was associated with small to moderate
improvement in knee pain149. A Cochrane review concluded evi-
dence for an effect of bracing for medial knee OA on symptoms,
function, and quality of life was inconclusive; evidence was mod-
erate for a lack of effect from lateral wedge vs neutral insoles on
symptoms and function150.
Structural outcomes of non-pharmacologic treatments
Only one study emerged in this category. In a randomized
clinical trial in persons with painful patellofemoral OA, a
L. Sharma / Osteoarthritis and Cartilage 24 (2016) 36e4842patellofemoral brace reduced patellofemoral but not tibiofemoral
bone marrow lesion volume and pain at 6 weeks131.
Prevalence and impact of OA
In two large referral centers in Cameroon, individuals tended to
present for care at later stages of disease; among 148 with knee OA,
moderate to severe disease was present in 36%, bilateral and
bicompartmental disease in 38.5%, and bilateral tricompartmental
disease in 14.2%132. Pain and radiographic severity did not corre-
late132. Another report described the prevalence of lumbar OA in
Chinese adults (approximately 9%), with no difference between
urban, suburban, and rural populations; higher prevalence was
linked to gender (female), age, obesity, physical work, work
posture, exposure to vibration during work, and duration of
sleep133. In the Framingham Osteoarthritis Study, the age-
standardized prevalence of radiographic hip OA was 19.6%; preva-
lence of radiographic (but not symptomatic) hip OA was higher in
men134. The prevalence of OA features by ultrasound was described
in participants from the Newcastle thousand families birth
cohort135. In a large sample of residents of Malm€o, Sweden, 25% had
radiographic knee OA and 15% had either symptomatic or clinically
deﬁned knee OA136.
In the Global Burden of Disease 2010 study, of 291 conditions,
hip and knee OA was ranked as the 11th highest contributor to
global disability and as the 38th highest in disability-adjusted life
years. While the global age-standardized prevalence of knee and
hip OA did not change from 1990 to 2010, years lived with disability
increased from 10.5 million in 1990 to 17.1 million in 2010137.
In cardiovascular populations (UK family practices), the co-
morbid addition of OA was associated with incrementally poorer
physical health (by SF-12 Physical Component Summary) but in-
teractions were less than additive138. Patients with symptomatic
OA at multiple sites (from the Genetics Arthrosis and Progression
study and the Osteoarthritis Care Clinic study) who consulted
health care providers for their OA were not at higher risk of death
than the general population139.
Health services research
A study of national cohorts of individuals with knee OA
assembled using data from the 2003, 2006, and 2009 waves of the
Medicare Current Beneﬁciary Survey revealed an increase in
opioid prescribing between 2003 and 2009140. Correlates of opioidTable II
OA research priorities, adapted from a report from a EULAR ad hoc expert committee147
Epidemiology Progressive OA disease course (mechanisms and risk factors, pr
Early phases in OA development (criteria to deﬁne early or pre
Criteria to diagnose and classify generalized or multisite OA
Multidimensionality of OA outcomes (pain, function, participat
Foot OA
Pathogenesis Tissue communication in OA
Non-cartilage articular pathology
Mechanisms by which comorbidities inﬂuence OA process
Joint trauma and subsequent repair
Pathology at earliest stages of OA
Relationship between pain and structure
Imaging and
biomarkers
Performance metrics of imaging and other biomarkers
Relevance of biomarkers to a broad range of domains
Deﬁning predictors of progression, especially those that aid tar
biomarkers)
Therapy Mechanisms of OA pain (origin of pain, its interrelation with ot
Individualized or pathology-targeted therapies (advance knowl
pharmacological therapies)
Optimal combination therapy strategies (using complex interve
pharmacological, non-pharmacological, and mixed approaches)use included gender (female), functional limitation, poor self-
reported health status, chronic obstructive pulmonary disease,
and musculoskeletal disease apart from OA140. In patients
attending outpatient medicine and specialty clinics in the US, 16%
rejected DMOADS under all conditions, 5% did not want to
perform subcutaneous injections and would only consider
DMOADs under the best-case scenario, 20% were willing to take
DMOADS under the best-case but would start rejecting them as
risk increased, and 59% would accept DMOADs across all
scenarios141.
Duloxetine (vs comparators celecoxib, diclofenac, naproxen,
hydromorphone, and oxycodone) was cost effective for 55-year old
pts with OA and more so in older patients and those at greater risk
for adverse effects in Canada142. Celecoxib with a proton pump
inhibitor was cost effective for OA (vs diclofenac with a proton
pump inhibitor) in an analysis within the Swedish health system
using an adaptation of the NICE OA model143.
A systematic review revealed well-developed, feasible in-
dicators of quality of care for OA which could be implemented in
primary care144. Sponsored by the European League Against
Rheumatism and the European Community, patient-centered and
consensus based standards of care for OA were developed using
systematic review and a 3-round Delphi process towards a goal of
harmonizing treatment and care of OA within Europe145.
Another report demonstrated a substantial increase in OA-
related costs resulting from expanding total knee replacement
eligibility criteria in the US, suggesting the need for more effective
nonoperative therapies146.
Special reports e research priorities
A EULAR ad hoc expert committee concluded that research
priorities include: predictors of OA progression (especially to
enable stratiﬁed intervention); better understanding of mecha-
nisms of OA pain; improved understanding of tissue communica-
tion; developing concepts of, and consequently interventions for,
early OA; and a need for new therapeutic strategies (pathology-
targeted and optimal combinations)147 The recommendations of
this report are summarized in Table II.
A prioritized research agenda about OA management was
developed for the Patient-Centered Outcomes Research Institute;
this report describes prioritized evidence gaps and top-ranked
research priorities as well as recommended study designs or sug-
gested analyses to address these gaps and priorities148.ediction tool for clinical and research purposes, progressor phenotype)
-OA)
ion, performance)
geted interventions (including combining imaging, biomechanical, biochemical
her aspects of disease, in order to identify novel targets for pain management)
edge of phenotypes of OA to target speciﬁc pharmacological and non-
ntion designs comparing monotherapy as well as speciﬁc combinations of
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While much was accomplished in the past year, this review also
illustrates directions for further work. Besides the obvious need to
develop novel pharmacologic and non-pharmacologic in-
terventions, future effort might include studies concerning: the
relationship between physical activity and OA disease progression,
modiﬁable determinants of physical activity behavior; in-
terventions targeting physical activity, knee conﬁdence, knee
buckling; role of falls and fracture in OA, risk factors for falls and
fracture; deﬁnitions of early OA, prevention/intervention efforts at
pre- or early disease stages; identiﬁcation/delineation of clinical
phenotypes; the role of muscle function and quality in OA; po-
tential disease-modifying effects of non-pharmacologic in-
terventions; risk factors for incident and progressive hand OA, foot
OA, hip OA; long-term pain outcome; and true disability outcome.
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